Target intelligence / Profile preview

Transporter associated with antigen processing (TAP)

Target
TAP
Molecular classification
ABC transporter, Transporter, Transmembrane protein
01

Overview

The Transporter associated with antigen processing (TAP) is a critical heterodimeric protein complex, consisting of TAP1 (ABCB2) and TAP2 (ABCB3) subunits, located in the endoplasmic reticulum (ER) membrane (UniProt P21964, P35670). It belongs to the ATP-binding cassette (ABC) transporter family and plays a central role in the MHC class I antigen presentation pathway by pumping proteasome-generated peptides from the cytosol into the ER lumen (Abele & Tampé, 2004). Once inside the ER, these peptides are loaded onto MHC class I molecules for subsequent display on the cell surface to CD8+ cytotoxic T lymphocytes. Deficiencies or downregulation of TAP are frequently observed in various cancers, allowing tumors to evade immune detection by reducing the presentation of neoantigens (NIH Gene ID: 6890). Conversely, many viruses have evolved specific proteins, such as ICP47 from herpes simplex virus and US6 from cytomegalovirus, to inhibit TAP function and escape the host immune response (Wikipedia). While there are currently no FDA-approved small molecule drugs specifically targeting TAP, it remains a significant area of research for immunotherapy, cancer vaccines, and the treatment of autoimmune disorders.

Other names
Antigen peptide transporterTAP1/TAP2 complexABCB2/ABCB3 complexPeptide transporter TAPATP-binding cassette sub-family B member 2/3
02

Mechanism of action

Inhibition of ATP-dependent peptide transport into the endoplasmic reticulum, preventing MHC class I assembly and surface expression.

03

Biological functions

Antigen processingAntigen presentationImmune responseMHC class I peptide loadingPeptide transport
04

Disease associations

CancerInfectionBare lymphocyte syndrome type IAutoimmune disease
05

Safety considerations

Systemic immunosuppressionIncreased susceptibility to viral infectionsImpaired CD8+ T-cell responsePotential for autoimmune reactions if modulated
06

Interacting drugs

ICP47 (viral inhibitor)

4 more in the full profile.

07

Biomarkers

TAP1 expression levelsTAP2 expression levelsMHC class I surface expressionCD8+ T-cell infiltration

Beyond the preview

Go deeper on Transporter associated with antigen processing (TAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transporter associated with antigen processing (TAP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call